Oral GLP-1 drug promotes substantial weight loss in trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York…